NRG-CC015: Harnessing E-Mindfulness Approaches for Living After Breast Cancer-HEAL-ABC

Objective

NRG-CC015 is a prospective, randomized phase III clinical trial to evaluate the efficacy of two distinct digital approaches for delivering a mindfulness-based intervention: a live, instructor-led version delivered over Zoom (MAPs LO), and an app-based, self-paced version (MAPs App). Participants will include younger breast cancer survivors (BCS) who were diagnosed with breast cancer at or before age 50 years, have completed their primary cancer treatment (i.e., surgery, radiation, and/or chemotherapy) at least 6 months earlier, and report elevated depressive symptoms.

National Clinical Trial (NCT) Number: 06748222

National Library of Medicine clinicaltrials.gov Website Address: https://clinicaltrials.gov/study/NCT06748222

Location: Essentia Health Cancer Centers

Research Study Categories

• Adult Oncology Studies

Specialties

• Breast Cancer
• Cancer Control/Prevention

Contact

Cancer Clinical Trials at 218-786-3308 or 844-681-7944, [email protected]